Internal Medicine, Pulmonary Disease · New York, NY
NPI
1679566673
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
425 W 59th St, 8th Floor
New York, NY, 10019
Phone (212) 492-5500
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,500 services
Medicare patients, 2024
548
Average age 75
Drug cost, 2024
$1.6M
2,449 prescriptions
Company payments, 2025
$285
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward Eden was code 99213 (office e&m - established), 245 times for 179 patients. In total Edward Eden billed 1,500 services in 29 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 245 | 179 | $73.29 | $18K |
| 99214 Office E&M - Established | Office | 179 | 132 | $103.43 | $19K |
| 94060 Pulmonary Function Testing | Facility | 160 | 156 | $8.11 | $1,298 |
| 94729 Pulmonary Function Testing | Facility | 153 | 151 | $7.07 | $1,082 |
| 94726 Pulmonary Function Testing | Facility | 149 | 147 | $9.38 | $1,398 |
| 94729 Pulmonary Function Testing | Office | 98 | 96 | $50.03 | $4,903 |
| 94726 Pulmonary Function Testing | Office | 97 | 95 | $47.74 | $4,631 |
| 94060 Pulmonary Function Testing | Office | 95 | 93 | $33.42 | $3,175 |
| 99204 Office E&M - New | Office | 85 | 85 | $140.73 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 44 | 29 | $68.34 | $3,007 |
| 99203 Office E&M - New | Office | 28 | 28 | $86.19 | $2,413 |
| 99223 Hospital E&M - Initial | Facility | 22 | 20 | $150.29 | $3,306 |
| 94618 Pulmonary Function Testing | Facility | 20 | 20 | $17.79 | $356 |
| 99222 Hospital E&M - Initial | Facility | 17 | 17 | $113.61 | $1,931 |
| 94200 Pulmonary Function Testing | Facility | 15 | 15 | $2.42 | $36.33 |
By year: 2022 $73K for 1,405 services; 2023 $80K for 1,653 services; 2024 $81K for 1,500 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 12 | 12 | $8.65 | $104 |
Medicare prescription drug claims, 2024
In 2024, the drug Edward Eden prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 422 prescriptions and refills. In total Edward Eden wrote 2,449 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 422 | 469 | 122 | $12K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 183 | 191 | 37 | $86K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 164 | 177 | 39 | $107K |
| Prednisone Generic | 164 | 170 | 66 | $533 |
| Breo Ellipta Fluticasone/Vilanterol | 105 | 122 | 32 | $46K |
| Montelukast Sodium Generic | 102 | 178 | 28 | $808 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 84 | 90 | 16 | $43K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 76 | 94 | 24 | $13K |
| Incruse Ellipta Umeclidinium Bromide | 73 | 77 | 21 | $26K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 73 | 95 | 26 | $9,671 |
| Arnuity Ellipta Fluticasone Furoate | 65 | 70 | 15 | $14K |
| Azelastine Hcl Generic | 64 | 114 | 28 | $1,761 |
| Ventolin Hfa Albuterol Sulfate | 62 | 77 | 17 | $4,269 |
| Symbicort Budesonide/Formoterol Fumarate | 55 | 59 | 17 | $13K |
| Azithromycin Generic | 53 | 62 | 24 | $557 |
Brand drugs: 1,497 claims; generic drugs: 952 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward Eden $285 ($285 in general payments such as food, travel and fees) from 5 companies. The largest payer was Insmed, Inc. with $151.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.